1. An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma. (7th July 2022) Authors: He, Cheng; Yang, Jing; Jin, Zheng; Zhu, Ying; Hu, Wei; Zeng, Lingfeng; Li, Xiaocheng Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anisi Stellati Fructus, a Significant Traditional Chinese Medicine (TCM) Herb and Its Bioactivity against Gastric Cancer. (9th May 2022) Authors: Khan, Maryam; Shamim, Saba Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Calycosin Improves Intestinal Mucosal Barrier Function after Gastrectomy in Rats through Alleviating Bacterial Translocation, Inflammation, and Oxidative Stress. (26th June 2022) Authors: Peng, Hui; Jin, Lei; Zhang, Qi; Shen, Yi; Wang, Zhen; Zhou, Fuhai; Yu, Qingsheng Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma. (3rd June 2022) Authors: Pang, Runming; Qin, Chunxin Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma. (13th July 2022) Authors: Yan, Shufang; Shang, Qinyu; Zhu, Haipeng; Chen, Ken; Li, Xinxia; Gao, Hongliang; Liu, Bo; Feng, Mei; Gao, Lixia Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of Dexamethasone versus Dexmedetomidine Combined with Local Anaesthetics in Brachial Plexus Block: A Meta-Analysis and Systematic Review. (1st March 2022) Authors: Li, Ming; Zhang, Pinghu; Wei, Duangao Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism. (31st July 2022) Authors: Zhou, Liang; Chen, Qijiu; Chen, Hui; Wang, Li; Zhang, Jianyong Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Exploration of Potential Biomarkers and Immune Landscape for Hepatoblastoma: Evidence from Machine Learning Algorithm. (31st July 2022) Authors: Zhou, Peng; Gao, Shanshan; Hu, Bin Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking. (19th July 2022) Authors: Wu, Chengfu; Zheng, Wenli; Zhang, Jifa; He, Xingping Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991. (3rd March 2022) Authors: Wu, Chao; Zhang, Jiajin; Wang, Kuan; Fan, Mengjiao; Hu, Yi Other Names: Li Qing Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗